DRUG COMPANY TAKEOVERS ON RISE SINCE THE CRASH

Pharmaceutical companies, once immune to hostile takeovers, suddenly seem more vulnerable in the wake of the stock market crash and the sharp decline in the value of the dollar. Financial analysts and investors are re-evaluating the drug industry in light of recent takeover bids. They're finding bargains among the battered

JOC Member Preview. To continue reading, login or register below.